|Articles|November 1, 2012

Nonsurgical alternatives for treating lentigo maligna require caution

With a dearth of data regarding nonsurgical treatments for lentigo maligna (LM) and lentigo maligna melanoma (LMM), current American Academy of Dermatology guidelines advise caution regarding these therapies, said James M. Grichnik, M.D., Ph.D., at the academy's 70th annual meeting.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME